Company
United StatesPublic company, NASDAQ: MGNXMacroGenics, Inc (NASDAQ: MGNX), Rockville, MD – FDA Inspections
Inspection records and compliance data for MacroGenics, Inc in Rockville, Maryland. 3 FDA inspections on record, 1 Form 483, last inspected September 22, 2023. Publicly traded as NASDAQ: MGNX.
Company Profile
This profile covers MacroGenics, Inc based in Rockville, Maryland, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 2
- Form 483s
- 1
- Warning letters
- 0
First inspected July 2, 2013. Last inspected September 22, 2023.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 22, 2023 | NAI | Human Drugs · Bioresearch Monitoring | 1219746 |
| August 28, 2023 | VAI | Human Drugs · Drug Quality Assurance | 1218479 |
| July 2, 2013 | NAI | Human Drugs · Bioresearch Monitoring | 838791 |
FDA documents
Form 483s (2)
EIRs (1)
People (5)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
MacroGenics, Inc
Stock ticker
MGNX
Exchange
NASDAQ
Share price
$2.29
Market cap
$146.4M
Price as of
November 13, 2026
FEI Number
3010195035
Address
9704 Medical Center Dr, Rockville, Maryland 20850, United States
Country
United States
ID: aaffc8e7-a7dc-4595-a5fb-2e95ee9315d1